Adaptive Treatment for Adolescent Anorexia Nervosa

Sponsor
Stanford University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03097874
Collaborator
University of California, San Francisco (Other), National Institutes of Health (NIH) (NIH), National Institute of Mental Health (NIMH) (NIH)
150
2
2
66.9
75
1.1

Study Details

Study Description

Brief Summary

The investigators are conducting a randomized controlled trial using an adaptive design for adolescents (ages 12-18) with anorexia nervosa to compare standard Family Based Treatment (FBT) to adaptive FBT with an Intensive Parental Coaching (IPC) component. If participants do not reach expected milestones by session 4 of treatment, participants may be randomized to receive additional IPC or continue treatment as usual with regular FBT.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family Based Treatment
  • Behavioral: Family Based Treatment + Intensive Parental Coaching
N/A

Detailed Description

Potential subjects aged 12 to 18 with anorexia nervosa (AN) will be recruited from Stanford University, University of California, San Francisco, other bay-area medical programs and clinics, and online advertisement to the population at large. If participants are deemed eligible, participants will be invited for a baseline interview (about 2 hours in duration) during which the investigators will conduct interviews and collect questionnaire measures. Then, participants and participants' families will begin Family Based Treatment (FBT) with a study therapist at Stanford University or University of California, San Francisco, respectively. All assessments and treatments are conducted through tele-health.

At session 4, if participants have not gained 2.4kg, an indicator of early treatment response, participants and participants' families will be randomized to receive either treatment as usual (FBT) or an adaptive form of FBT, during which families will receive additional Intensive Parental Coaching (IPC). If participants have reached weight milestones (i.e., 2.4kg at session 4), participants will continue FBT as usual.

At 3 months of treatment and end of treatment, the investigators will collect the same measures taken at baseline. The investigators also ask that families participate in 6- and 12-month follow-up, respectively.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Confirming the Efficacy/Mechanism of an Adaptive Treatment for Adolescent Anorexia
Actual Study Start Date :
Sep 1, 2017
Anticipated Primary Completion Date :
Mar 31, 2023
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Family Based Treatment

Family Based Treatment of adolescent Anorexia Nervosa

Behavioral: Family Based Treatment
Family Based Treatment of adolescent Anorexia Nervosa
Other Names:
  • Maudsley Method
  • Experimental: Family Based Treatment + Intensive Parental Coaching

    Family Based Treatment plus Intensive Parental Coaching if weight milestones are not met by session 4.

    Behavioral: Family Based Treatment + Intensive Parental Coaching
    Family Based Treatment of adolescent Anorexia Nervosa plus an Intensive Parental Coaching component.
    Other Names:
  • FBT + IPC
  • Outcome Measures

    Primary Outcome Measures

    1. Estimated Body Weight (EBW) [following 9 months of treatment]

      individual with anorexia nervosa's body weight at end of treatment

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 12-18 years of age and living with participants' families

    • meeting DSM-5 criteria for AN (both subtypes) except for the amenorrhea requirement

    • medically stable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine.

    Exclusion Criteria:
    • associated physical illness that necessitates hospitalization

    • psychotic illness, mental retardation, or any other mental illnesses that would prohibit the use of psychotherapy

    • current dependence on drugs or alcohol

    • physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight

    • previous FBT

    • currently taking medication for co-morbid disorders that cannot be safely discontinued on a stable dose for less than 2 months

    • in the case of patients with current, or a history of sexual or physical abuse by family members, perpetrators of the abuse will be excluded from treatment.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of California, San Francisco San Francisco California United States 94143
    2 Stanford University School of Medicine Stanford California United States 94305-5723

    Sponsors and Collaborators

    • Stanford University
    • University of California, San Francisco
    • National Institutes of Health (NIH)
    • National Institute of Mental Health (NIMH)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    James Dale Lock, MD, PhD, Stanford University
    ClinicalTrials.gov Identifier:
    NCT03097874
    Other Study ID Numbers:
    • 1R01MH110538
    • SPO 121859
    • 1R01MH110538-01A1
    First Posted:
    Mar 31, 2017
    Last Update Posted:
    Jan 14, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by James Dale Lock, MD, PhD, Stanford University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 14, 2022